These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8396223

  • 1. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
    Adams EF, Brockmeier S, Friedmann E, Roth M, Buchfelder M, Fahlbusch R.
    Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223
    [Abstract] [Full Text] [Related]

  • 2. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
    Sakai N, Kim K, Sanno N, Yoshida D, Teramoto A, Shibasaki T.
    Neurol Med Chir (Tokyo); 2008 Aug; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
    Kim HJ, Kim MS, Park YJ, Kim SW, Park DJ, Park KS, Kim SY, Cho BY, Lee HK, Jung HW, Han DH, Lee HS, Chi JG.
    J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients.
    Yang I, Park S, Ryu M, Woo J, Kim S, Kim J, Kim Y, Choi Y.
    Eur J Endocrinol; 1996 Jun; 134(6):720-6. PubMed ID: 8766942
    [Abstract] [Full Text] [Related]

  • 5. Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes.
    Buchfelder M, Fahlbusch R, Merz T, Symowski H, Adams EF.
    Pituitary; 1999 May; 1(3-4):181-5. PubMed ID: 11081196
    [Abstract] [Full Text] [Related]

  • 6. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
    Shi Y, Tang D, Deng J, Su C.
    Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
    [Abstract] [Full Text] [Related]

  • 7. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase.
    Spada A, Arosio M, Bochicchio D, Bazzoni N, Vallar L, Bassetti M, Faglia G.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1421-6. PubMed ID: 1977758
    [Abstract] [Full Text] [Related]

  • 8. Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein.
    Landis CA, Harsh G, Lyons J, Davis RL, McCormick F, Bourne HR.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1416-20. PubMed ID: 2121775
    [Abstract] [Full Text] [Related]

  • 9. GS protein mutations and pituitary tumors: functional correlates and possible therapeutic implications.
    Faglia G, Arosio M, Spada A.
    Metabolism; 1996 Aug; 45(8 Suppl 1):117-9. PubMed ID: 8769403
    [Abstract] [Full Text] [Related]

  • 10. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
    Persani L, Borgato S, Lania A, Filopanti M, Mantovani G, Conti M, Spada A.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
    [Abstract] [Full Text] [Related]

  • 11. Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas.
    Barlier A, Gunz G, Zamora AJ, Morange-Ramos I, Figarella-Branger D, Dufour H, Enjalbert A, Jaquet P.
    J Clin Endocrinol Metab; 1998 May; 83(5):1604-10. PubMed ID: 9589663
    [Abstract] [Full Text] [Related]

  • 12. Gps mutations in Chilean patients harboring growth hormone-secreting pituitary tumors.
    Johnson MC, Codner E, Eggers M, Mosso L, Rodriguez JA, Cassorla F.
    J Pediatr Endocrinol Metab; 1999 May; 12(3):381-7. PubMed ID: 10821217
    [Abstract] [Full Text] [Related]

  • 13. Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.
    Adams EF, Lei T, Buchfelder M, Bowers CY, Fahlbusch R.
    Mol Endocrinol; 1996 Apr; 10(4):432-8. PubMed ID: 8721987
    [Abstract] [Full Text] [Related]

  • 14. Gs protein mutations and the pathogenesis and function of pituitary tumors.
    Harris PE.
    Metabolism; 1996 Aug; 45(8 Suppl 1):120-2. PubMed ID: 8769404
    [Abstract] [Full Text] [Related]

  • 15. Heterozygous gsp mutation renders ion channels of human somatotroph adenoma cells unresponsive to growth hormone-releasing hormone.
    Yasufuku-Takano J, Takano K, Takei T, Fukumoto S, Teramoto A, Takakura K, Yamashita N, Fujita T.
    Endocrinology; 1999 May; 140(5):2018-26. PubMed ID: 10218950
    [Abstract] [Full Text] [Related]

  • 16. Molecular biology of growth-hormone-secreting human pituitary tumours: biochemical consequences and potential clinical significance.
    Adams EF, Buchfelder M, Lei T, Petersen B, Fahlbusch R.
    Acta Neurochir Suppl; 1996 May; 65():7-10. PubMed ID: 8738483
    [Abstract] [Full Text] [Related]

  • 17. Does the prevalence of gsp mutations in GH-secreting pituitary adenomas differ geographically or racially? Prevalence of gsp mutations in Japanese patients revisited.
    Yasufuku-Takano J, Takano K, Morita K, Takakura K, Teramoto A, Fujita T.
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):91-6. PubMed ID: 16402935
    [Abstract] [Full Text] [Related]

  • 18. Ghrelin mRNA and GH secretagogue receptor mRNA in human GH-producing pituitary adenomas is affected by mutations in the alpha subunit of G protein.
    Kim K, Sanno N, Arai K, Takano K, Yasufuku-Takano J, Teramoto A, Shibasaki T.
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):630-6. PubMed ID: 14616888
    [Abstract] [Full Text] [Related]

  • 19. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
    Xu T, Ye F, Wang B, Tian C, Wang S, Shu K, Guo D, Lei T.
    Neuro Endocrinol Lett; 2010 Nov; 31(1):147-54. PubMed ID: 20150876
    [Abstract] [Full Text] [Related]

  • 20. cAMP pathway and pituitary tumorigenesis.
    Lania A, Mantovani G, Spada A.
    Ann Endocrinol (Paris); 2012 Apr; 73(2):73-5. PubMed ID: 22525824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.